CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts

Details for Australian Patent Application No. 2008206502 (hide)

Owner Boehringer Ingelheim International GmbH Yale University

Inventors Vignery, Agnes; Li, Jun; Ke, Juan Zhang

Agent Davies Collison Cave

Pub. Number AU-A-2008206502

PCT Pub. Number WO2008/089022

Priority 60/880,094 11.01.07 US

Filing date 10 January 2008

Wipo publication date 24 July 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

20 August 2009 PCT application entered the National Phase

  PCT publication WO2008/089022 Priority application(s): WO2008/089022

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008206511-Fibers made from copolymers of ethylene/alpha-olefins

2008206495-6-substituted indole-3-carboxylic acid amide compounds having Sphingosine1-Phosphate (S1P) receptor antagonist biological activity